425 related articles for article (PubMed ID: 32767257)
1. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
2. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
4. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
5. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
6. Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Jeong I; Kang SK; Kwon WS; Kim HJ; Kim KH; Kim HM; Lee A; Lee SK; Bogenrieder T; Chung HC; Rha SY
J Cell Mol Med; 2018 Dec; 22(12):5899-5908. PubMed ID: 30247804
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
Zhu M; Liang Q; Chen T; Kong Q; Ye G; Yu S; Li X; He Q; Liu H; Hu Y; Yu J; Li G
Clin Epigenetics; 2021 Jan; 13(1):22. PubMed ID: 33514440
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer.
Zhao J; Liang Q; Cheung KF; Kang W; Dong Y; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Br J Cancer; 2013 Jun; 108(12):2557-64. PubMed ID: 23722468
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
11. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
12. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
13. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines.
Li J; Liu X; Liu M; Che K; Luo B
Dig Liver Dis; 2016 Jun; 48(6):673-80. PubMed ID: 27026080
[TBL] [Abstract][Full Text] [Related]
14. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract][Full Text] [Related]
15. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.
Okada T; Nakamura M; Nishikawa J; Sakai K; Zhang Y; Saito M; Morishige A; Oga A; Sasaki K; Suehiro Y; Hinoda Y; Sakaida I
Cancer Sci; 2013 Oct; 104(10):1309-14. PubMed ID: 23829175
[TBL] [Abstract][Full Text] [Related]
16. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
[TBL] [Abstract][Full Text] [Related]
17. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.
Zhao Z; Liu W; Liu J; Wang J; Luo B
J Med Virol; 2017 Oct; 89(10):1844-1851. PubMed ID: 28543390
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
Zhang Z; Dai DQ
World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
[TBL] [Abstract][Full Text] [Related]
19. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway.
Dong M; Gong LP; Chen JN; Zhang XF; Zhang YW; Hui DY; Zhao XX; Wu XY; Shao CK
Cell Oncol (Dordr); 2020 Oct; 43(5):901-913. PubMed ID: 32533512
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
